I Cookies vengono usati per fornirti un servizio migliore. Proseguendo con la navigazione, acconsenti al loro utilizzo. Per negare il consenso o eliminarli dal tuo browser visita www.aboutcookies.org. Per maggiori informazioni leggi l'informativa.
Every two years the metastatic breast cancer community convenes to assess what needs to be done to bridge gaps Â– gaps in scientific/clinical knowledge and in service provision, and gaps between the patients and professional communities.
Most new cases of cancer occur in parts of the world that are least equipped to deal with them. As our contribution to helping improve access to prevention, treatment and care across the world, Cancer World has launched a new section, Our World, dedicated to examining the many challenges and providing a platform for profiling some of the global, regional and national initiatives and strategies that are making a real difference.
Flexibility and goodwill have allowed patient involvement in the work of EuropeÂ’s drug regulators to develop at an impressive pace. But will they be enough to withstand the strains on the relationship exerted by financial pressures, together with demands that patient reps stop seeing industry reps?
The revised European Cancer Code, launched last October, gives clear and concise information on what people can do to lower their own cancer risk. But until policy makers Â– and doctors Â– take prevention more seriously, millions of lives will continue to be lost unnecessarily.